IGT-302

N/A

Report date: 2025/03/17 16:18:28

Base Information

Drug NameIGT-302
Drug Alias NameIGT-302
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionTEK receptor tyrosine kinase agonists
TargetsTEK receptor tyrosine kinase
Therapy Area/IndicationsGlaucoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIngenia Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesIngenia Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsGlaucoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A